BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnson AP, Potz N, Waight P, Gungabissoon U, Livermore DM, Pebody R, Miller E, George RC. Susceptibility of pneumococci causing meningitis in England and Wales to first-line antimicrobial agents, 2001-2004. J Antimicrob Chemother 2005;56:1181-2. [PMID: 16219757 DOI: 10.1093/jac/dki381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Jit M. The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis. J Infect 2010;61:114-24. [PMID: 20433866 DOI: 10.1016/j.jinf.2010.04.008] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
2 Johnson AP, Waight P, Andrews N, Pebody R, George RC, Miller E. Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in England. Journal of Infection 2007;55:394-9. [DOI: 10.1016/j.jinf.2007.07.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
3 Hanquet G, Kissling E, Fenoll A, George R, Lepoutre A, Lernout T, Tarragó D, Varon E, Verhaegen J. Pneumococcal serotypes in children in 4 European countries. Emerg Infect Dis. 2010;16:1428-1439. [PMID: 20735928 DOI: 10.3201/eid1609.100102] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 6.1] [Reference Citation Analysis]